under the radar, page-6

im with u 2 horsey

sads, i wouldnt be too quick to the exit door, take some off the table sure, but i feel this one has a pretty good medium term future as revenues come in, royaltys are revealed and fund the next arrow in the quiver...

so no integrase deal yet hey, with some questioning tibotec and delays... i suspect avx has delayed the thing to keep their option open to retain the integrase program if an atc deal is finalised in the short term and milestone payments can fund integrase progress...

integrase is hot atm, avx appear to have some significant options, and a previous quote from the co

"ATC is complementary to Avexa?s existing HIV integrase
project. The opportunity exists for Avexa to realise a potential blockbuster HIV drug by combining ATC (a new NRTI
inhibitor) with a future new integrase inhibitor. This could
provide an especially effective new combination treatment
against HIV." so I suggest jc x2, young Nath and the boys may have a bigger picture in mind...

so make sure you keep a tidy parcel or reinvest well...